(Q37152832)

18 August 2017

1 reference

title

Easypod: a new electronic injection device for growth hormone (English)

1 reference

18 August 2017

Jovanna Dahlgren

1

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Expert Review of Medical Devices

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

297-304

1 reference

Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Noonan syndrome: relationships between genotype, growth, and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Final height in short children born small for gestational age treated with growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Consensus statement on the management of the GH-treated adolescent in the transition to adult care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Clinical review: Growth hormone and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Understanding and meeting the needs of those using growth hormone injection devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Factors determining patient choice of device for GH therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Risk of needlestick injuries by injection pens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

HumaPen Memoir: a novel insulin-injecting pen with a dose-memory feature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Functionality and acceptability of a new electronic insulin injection pen with a memory feature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

Epidemiological, endocrine and metabolic features in Turner syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.3.297

21 January 2018

Identifiers

DOI

10.1586/17434440.5.3.297

1 reference

18 August 2017

1 reference